HIF-1α siRNA Enhances the Efficacy of Erlotinib in Non-small Cell Lung Cancer - A Novel Strategy to Reverse Hypoxia-Induced Drug Resistance
Favorite
Share
More Options
15

Open in WPS to view all 15 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
